Atherectomy and Thrombectomy Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

Description

Persistence Market Research offers an extensive analysis of the global Atherectomy and Thrombectomy Devices Market, providing comprehensive insights into market dynamics, growth drivers, challenges, and emerging trends. This report serves as a valuable resource for stakeholders, offering detailed data and statistics to navigate the market landscape from 2024 to 2032.

The Global Energy Storage Market is expected to surge ahead at a CAGR of 5.7%, thereby increasing from a value of US$ 3.9 billion in 2024 to US$ 6 billion by the end of 2032.

Key Insights:

Estimated Market Value (2024): USD 3.9 Billion
Projected Market Value (2032): USD 6 Billion
Global Market Growth Rate (CAGR 2024 to 2032): 5.7%

Atherectomy and Thrombectomy Devices Market - Report Scope:

The increasing prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is driving the demand for atherectomy and thrombectomy devices. These devices are used to remove plaque buildup and blood clots from arteries, thereby restoring blood flow and reducing the risk of cardiovascular events. Technological advancements, such as the development of laser atherectomy and aspiration thrombectomy systems, are enhancing the efficacy and safety of these procedures, further fueling market growth.

Market Growth Drivers:

The growing burden of cardiovascular diseases, coupled with the rising adoption of minimally invasive procedures, is a key driver of market growth. Atherectomy and thrombectomy devices offer several advantages over traditional surgical techniques, including reduced risk of complications, shorter recovery times, and improved patient outcomes. Moreover, advancements in device design and technology have led to the development of next-generation devices with enhanced precision and effectiveness. Additionally, increasing healthcare expenditure and improving healthcare infrastructure in emerging economies are expected to contribute to market expansion.

Market Restraints:

Despite the numerous benefits of atherectomy and thrombectomy devices, certain challenges hinder market growth. These include the high cost of devices and procedures, limited reimbursement coverage, and regulatory hurdles associated with device approval. Moreover, the complexity of endovascular procedures and the need for specialized training may limit the adoption of these devices among healthcare providers. Additionally, concerns regarding the long-term durability and safety of atherectomy and thrombectomy devices may impact patient and physician confidence, thereby restraining market growth.

Market Opportunities:

The Atherectomy and Thrombectomy Devices Market presents significant opportunities for innovation and expansion. Manufacturers are investing in research and development activities to introduce novel technologies and devices that address unmet needs in the treatment of cardiovascular diseases. For example, advancements in imaging modalities, such as intravascular ultrasound and optical coherence tomography, enable real-time visualization of arterial structures and plaque composition, guiding more precise interventions. Furthermore, strategic collaborations and partnerships between device manufacturers and healthcare providers can facilitate technology transfer and accelerate market penetration in emerging markets.

Key Questions Addressed in the Report:

What is the Expected Value CAGR of the Atherectomy and Thrombectomy Devices Market?
What are the Key Factors Driving the Growth of the Atherectomy and Thrombectomy Devices Market?
Which Region Holds the Largest Market Share in the Atherectomy and Thrombectomy Devices Market?
Who are the Key Players in the Global Atherectomy and Thrombectomy Devices Market?
What Strategies are Adopted by Leading Companies to Sustain Growth in the Atherectomy and Thrombectomy Devices Market?

Competitive Landscape and Business Strategies:

Leading players in the atherectomy and thrombectomy devices market include Medtronic plc, Boston Scientific Corporation, and Philips Healthcare. These companies focus on product innovation, strategic acquisitions, and geographic expansion to maintain their competitive edge. Strategies such as launching next-generation devices, investing in clinical research, and expanding distribution networks are commonly employed to drive growth. Additionally, partnerships with healthcare institutions and regulatory bodies enable companies to navigate complex regulatory landscapes and accelerate market entry.

Key Companies Profiled:

Medtronic plc
Boston Scientific Corporation
Philips Healthcare
Abbott Laboratories
Cardinal Health, Inc.
B. Braun Melsungen AG
Terumo Corporation
Cook Medical LLC
AngioDynamics, Inc.
Penumbra, Inc.

Atherectomy and Thrombectomy Devices Market Segmentation:

By Product Type:

Atherectomy Devices
Directional Atherectomy Devices
Rotational Atherectomy Devices
Laser Atherectomy Devices
Orbital Atherectomy Devices
Thrombectomy Devices
Aspiration Thrombectomy Devices
Mechanical Thrombectomy Devices
Rheolytic Thrombectomy Devices

By Application:

Coronary Artery Disease
Peripheral Artery Disease
Neurovascular Disease

By End User:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Product Code: PMRREP33105

1. Executive Summary

1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

3.1. Risk Assessment
- 3.1.1. COVID-19 Crisis and Impact on Atherectomy and Thrombectomy Devices Demand
- 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
- 3.1.3. Impact on Market Value (US$ Mn)
- 3.1.4. Assessment by Key Countries
- 3.1.5. Assessment by Key Market Segments
- 3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

4.1. Global Protective Coatings Market (US$ Mn)
4.2. Atherectomy and Thrombectomy Devices Market Opportunity Assessment (US$ Mn)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
  - 4.4.1.1. In Short Term
  - 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
  - 4.4.2.1. In Short Term
  - 4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Global Protective Coatings Market Growth
- 4.5.3. Atherectomy and Thrombectomy Devices Adoption Rate, By Country
4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. Atherectomy and Thrombectomy Devices Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

5.1. Manufacturers' Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6. Global Atherectomy and Thrombectomy Devices Market Demand Analysis 2019-2023 and Forecast, 2024-2032

6.1. Historical Market Analysis, 2019-2023
6.2. Current and Future Market Projections, 2024-2032
6.3. Y-o-Y Growth Trend Analysis

7. Global Atherectomy and Thrombectomy Devices Market Value Analysis 2019-2023 and Forecast, 2024-2032

7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Atherectomy and Thrombectomy Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Type

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Type, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2024-2032
- 8.3.1. Rheolytic
- 8.3.2. Aspiration
- 8.3.3. Rotational
- 8.3.4. Ultrasound Device
8.4. Market Attractiveness Analysis By Type

9. Global Atherectomy and Thrombectomy Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Application

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2032
- 9.3.1. Hospital
- 9.3.2. Clinic
- 9.3.3. Others
9.4. Market Attractiveness Analysis By Application

10. Global Atherectomy and Thrombectomy Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Region

10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2024-2032
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. Asia Pacific
- 10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Atherectomy and Thrombectomy Devices Market Analysis 2019-2023 and Forecast 2024-2032

11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2032
- 11.4.1. By Country
  - 11.4.1.1. U.S.
  - 11.4.1.2. Canada
  - 11.4.1.3. Rest of North America
- 11.4.2. By Type
- 11.4.3. By Application
11.5. Market Attractiveness Analysis
- 11.5.1. By Country
- 11.5.2. By Type
- 11.5.3. By Application

12. Latin America Atherectomy and Thrombectomy Devices Market Analysis 2019-2023 and Forecast 2024-2032

12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2032
- 12.4.1. By Country
  - 12.4.1.1. Brazil
  - 12.4.1.2. Mexico
  - 12.4.1.3. Rest of Latin America
- 12.4.2. By Type
- 12.4.3. By Application
12.5. Market Attractiveness Analysis
- 12.5.1. By Country
- 12.5.2. By Type
- 12.5.3. By Application

13. Europe Atherectomy and Thrombectomy Devices Market Analysis 2019-2023 and Forecast 2024-2032

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2032
- 13.4.1. By Country
  - 13.4.1.1. Germany
  - 13.4.1.2. France
  - 13.4.1.3. U.K.
  - 13.4.1.4. Italy
  - 13.4.1.5. Benelux
  - 13.4.1.6. Nordic Countries
  - 13.4.1.7. Rest of Europe
- 13.4.2. By Type
- 13.4.3. By Application
13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Type
- 13.5.3. By Application

14. Asia Pacific Atherectomy and Thrombectomy Devices Market Analysis 2019-2023 and Forecast 2024-2032

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2032
- 14.4.1. By Country
  - 14.4.1.1. China
  - 14.4.1.2. Japan
  - 14.4.1.3. South Korea
  - 14.4.1.4. Rest of Asia Pacific
- 14.4.2. By Type
- 14.4.3. By Application
14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Type
- 14.5.3. By Application

15. Middle East and Africa Atherectomy and Thrombectomy Devices Market Analysis 2019-2023 and Forecast 2024-2032

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2024-2032
- 15.4.1. By Country
  - 15.4.1.1. GCC Countries
  - 15.4.1.2. South Africa
  - 15.4.1.3. Turkey
  - 15.4.1.4. Rest of Middle East and Africa
- 15.4.2. By Type
- 15.4.3. By Application
15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Type
- 15.5.3. By Application

16. Key Countries Atherectomy and Thrombectomy Devices Market Analysis 2019-2023 and Forecast 2024-2032

16.1. Introduction
- 16.1.1. Market Value Proportion Analysis, By Key Countries
- 16.1.2. Global Vs. Country Growth Comparison
16.2. US Atherectomy and Thrombectomy Devices Market Analysis
- 16.2.1. Value Proportion Analysis by Market Taxonomy
- 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.2.2.1. By Type
  - 16.2.2.2. By Application
16.3. Canada Atherectomy and Thrombectomy Devices Market Analysis
- 16.3.1. Value Proportion Analysis by Market Taxonomy
- 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.3.2.1. By Type
  - 16.3.2.2. By Application
16.4. Mexico Atherectomy and Thrombectomy Devices Market Analysis
- 16.4.1. Value Proportion Analysis by Market Taxonomy
- 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.4.2.1. By Type
  - 16.4.2.2. By Application
16.5. Brazil Atherectomy and Thrombectomy Devices Market Analysis
- 16.5.1. Value Proportion Analysis by Market Taxonomy
- 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.5.2.1. By Type
  - 16.5.2.2. By Application
16.6. Germany Atherectomy and Thrombectomy Devices Market Analysis
- 16.6.1. Value Proportion Analysis by Market Taxonomy
- 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.6.2.1. By Type
  - 16.6.2.2. By Application
16.7. France Atherectomy and Thrombectomy Devices Market Analysis
- 16.7.1. Value Proportion Analysis by Market Taxonomy
- 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.7.2.1. By Type
  - 16.7.2.2. By Application
16.8. Italy Atherectomy and Thrombectomy Devices Market Analysis
- 16.8.1. Value Proportion Analysis by Market Taxonomy
- 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.8.2.1. By Type
  - 16.8.2.2. By Application
16.9. BENELUX Atherectomy and Thrombectomy Devices Market Analysis
- 16.9.1. Value Proportion Analysis by Market Taxonomy
- 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.9.2.1. By Type
  - 16.9.2.2. By Application
16.10. UK Atherectomy and Thrombectomy Devices Market Analysis
- 16.10.1. Value Proportion Analysis by Market Taxonomy
- 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.10.2.1. By Type
  - 16.10.2.2. By Application
16.11. Nordic Countries Atherectomy and Thrombectomy Devices Market Analysis
- 16.11.1. Value Proportion Analysis by Market Taxonomy
- 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.11.2.1. By Type
  - 16.11.2.2. By Application
16.12. China Atherectomy and Thrombectomy Devices Market Analysis
- 16.12.1. Value Proportion Analysis by Market Taxonomy
- 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.12.2.1. By Type
  - 16.12.2.2. By Application
16.13. Japan Atherectomy and Thrombectomy Devices Market Analysis
- 16.13.1. Value Proportion Analysis by Market Taxonomy
- 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.13.2.1. By Type
  - 16.13.2.2. By Application
16.14. South Korea Atherectomy and Thrombectomy Devices Market Analysis
- 16.14.1. Value Proportion Analysis by Market Taxonomy
- 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.14.2.1. By Type
  - 16.14.2.2. By Application
16.15. GCC Countries Atherectomy and Thrombectomy Devices Market Analysis
- 16.15.1. Value Proportion Analysis by Market Taxonomy
- 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.15.2.1. By Type
  - 16.15.2.2. By Application
16.16. South Africa Atherectomy and Thrombectomy Devices Market Analysis
- 16.16.1. Value Proportion Analysis by Market Taxonomy
- 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.16.2.1. By Type
  - 16.16.2.2. By Application
16.17. Turkey Atherectomy and Thrombectomy Devices Market Analysis
- 16.17.1. Value Proportion Analysis by Market Taxonomy
- 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2024-2032
  - 16.17.2.1. By Type
  - 16.17.2.2. By Application
- 16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
- 17.4.1. By Regional footprint of Players
- 17.4.2. Product footprint by Players

18. Competition Analysis

18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
- 18.3.1. Medtronic
  - 18.3.1.1. Overview
  - 18.3.1.2. Product Portfolio
  - 18.3.1.3. Sales Footprint
  - 18.3.1.4. Strategy Overview
- 18.3.2. Boston Scientific
  - 18.3.2.1. Overview
  - 18.3.2.2. Product Portfolio
  - 18.3.2.3. Sales Footprint
  - 18.3.2.4. Strategy Overview
- 18.3.3. Spectranetics
  - 18.3.3.1. Overview
  - 18.3.3.2. Product Portfolio
  - 18.3.3.3. Sales Footprint
  - 18.3.3.4. Strategy Overview
- 18.3.4. Bayer AG
  - 18.3.4.1. Overview
  - 18.3.4.2. Product Portfolio
  - 18.3.4.3. Sales Footprint
  - 18.3.4.4. Strategy Overview
- 18.3.5. Cardiovascular Systems
  - 18.3.5.1. Overview
  - 18.3.5.2. Product Portfolio
  - 18.3.5.3. Sales Footprint
  - 18.3.5.4. Strategy Overview
- 18.3.6. Argon Medical Devices
  - 18.3.6.1. Overview
  - 18.3.6.2. Product Portfolio
  - 18.3.6.3. Sales Footprint
  - 18.3.6.4. Strategy Overview
- 18.3.7. Getinge AB
  - 18.3.7.1. Overview
  - 18.3.7.2. Product Portfolio
  - 18.3.7.3. Sales Footprint
  - 18.3.7.4. Strategy Overview
- 18.3.8. Straub Medical AG
  - 18.3.8.1. Overview
  - 18.3.8.2. Product Portfolio
  - 18.3.8.3. Sales Footprint
  - 18.3.8.4. Strategy Overview
- 18.3.9. Teleflex
  - 18.3.9.1. Overview
  - 18.3.9.2. Product Portfolio
  - 18.3.9.3. Sales Footprint
  - 18.3.9.4. Strategy Overview
- 18.3.10. Terumo Medical
  - 18.3.10.1. Overview
  - 18.3.10.2. Product Portfolio
  - 18.3.10.3. Sales Footprint
  - 18.3.10.4. Strategy Overview
- 18.3.11. Abbott
  - 18.3.11.1. Overview
  - 18.3.11.2. Product Portfolio
  - 18.3.11.3. Sales Footprint
  - 18.3.11.4. Strategy Overview